NXP vs MS

For growth investors, Morgan Stanley (MS) is the stronger pick with 16.

8% revenue growth year-over-year, versus -63. 1% for Nuveen Select Tax-Free Income Portfolio (NXP). Morgan Stanley (MS) offers the better valuation at 24. 3x trailing P/E (16. 3x forward), making it the more compelling value choice. Analysts rate Morgan Stanley (MS) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Morgan Stanley (MS) is the cheapest at 24.

3x versus Nuveen Select Tax-Free Income Portfolio at 75. 7x.

Over the past 5 years, Morgan Stanley (MS) delivered a total return of +142.

2%, compared to +1. 2% for Nuveen Select Tax-Free Income Portfolio (NXP). Over 10 years, the gap is even starker: MS returned +739. 4% versus NXP's +33. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Nuveen Select Tax-Free Income Portfolio (NXP) is the lower-risk stock at 0.

10β versus Morgan Stanley's 1. 37β — meaning MS is approximately 1264% more volatile than NXP relative to the S&P 500. On balance sheet safety, Nuveen Select Tax-Free Income Portfolio (NXP) carries a lower debt/equity ratio of 4% versus 3% for Morgan Stanley — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Morgan Stanley (MS) is pulling ahead at 16.

8% versus -63. 1% for Nuveen Select Tax-Free Income Portfolio (NXP). On earnings-per-share growth, the picture is similar: Morgan Stanley grew EPS 53. 5% year-over-year, compared to -70. 8% for Nuveen Select Tax-Free Income Portfolio. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Nuveen Select Tax-Free Income Portfolio (NXP) is the more profitable company, earning 93.

9% net margin versus 13. 0% for Morgan Stanley — meaning it keeps 93. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NXP leads at 93. 9% versus 17. 1% for MS. At the gross margin level — before operating expenses — NXP leads at 97. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, MS (2.

0% yield) pays a dividend. NXP does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Nuveen Select Tax-Free Income Portfolio (NXP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

10)). Both have compounded well over 10 years (NXP: +33. 4%, MS: +739. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: NXP is a small-cap quality compounder stock; MS is a large-cap high-growth stock. MS pays a dividend while NXP does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.